Xiufeng Zheng

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

MET inhibitors as salvage therapy for MET-amplified gastric cancer with pulmonary lymphangitis.

MET inhibitors as salvage therapy for MET-amplified gastric cancer with pulmonary lymphangitis.

Journal: Precision clinical medicine

Published: August 12, 2024

Efficacy and advantage of immunotherapy for melanoma via intramuscular co-expression of plasmid-encoded PD-1 and CTLA-4 scFvs.

Efficacy and advantage of immunotherapy for melanoma via intramuscular co-expression of plasmid-encoded PD-1 and CTLA-4 scFvs.

Journal: American journal of cancer research

Published: February 27, 2024

Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review).

Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review).

Journal: Experimental and therapeutic medicine

Published: March 22, 2023

Enhancedanti-tumor efficacy through a combination of intramuscularly expressed DNA vaccine and plasmid-encoded PD-1 antibody.

Enhancedanti-tumor efficacy through a combination of intramuscularly expressed DNA vaccine and plasmid-encoded PD-1 antibody.

Journal: Frontiers in immunology

Published: February 20, 2023

Tissue factor as a new target for tumor therapy-killing two birds with one stone: a narrative review.

Tissue factor as a new target for tumor therapy-killing two birds with one stone: a narrative review.

Journal: Annals of translational medicine

Published: September 23, 2022

Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment.

Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment.

Journal: Cancer medicine

Published: July 21, 2022

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data.

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data.

Journal: Frontiers in pharmacology

Published: April 07, 2022

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma.

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma.

Journal: Frontiers in oncology

Published: November 29, 2021

Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.

Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.

Journal: Medicine

Published: July 29, 2021

Locally advanced gastroesophageal junction cancer with pathological complete response to neoadjuvant therapy: a case report and literature review.

Locally advanced gastroesophageal junction cancer with pathological complete response to neoadjuvant therapy: a case report and literature review.

Journal: Annals of translational medicine

Published: April 14, 2021

A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old.

A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old.

Journal: Frontiers in oncology

Published: February 28, 2021

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade.

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade.

Journal: Frontiers in oncology

Published: October 21, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026